Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats.
about
Therapeutic potential of the renin angiotensin system in ischaemic strokeMechanisms of the Anti-Ischemic Effect of Angiotensin II AT( 1 ) Receptor Antagonists in the BrainFrom hypertension to stroke: mechanisms and potential prevention strategies.The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: role of the renin angiotensin system inhibition.The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats.Enhanced expressions of microvascular smooth muscle receptors after focal cerebral ischemia occur via the MAPK MEK/ERK pathway.Postischemic administration of angiotensin II type 1 receptor blocker reduces cerebral infarction size in hypertensive rats.An angiotensin II type 1 receptor blocker can preserve endothelial function and attenuate brain ischemic damage in spontaneously hypertensive rats.Neurotrophic Signaling Factors in Brain Ischemia/Reperfusion Rats: Differential Modulation Pattern between Single-Time and Multiple Electroacupuncture Stimulation.A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention.Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protectionRole of central angiotensin receptors in scopolamine-induced impairment in memory, cerebral blood flow, and cholinergic function.Candesartan.Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.Differential effects of short-term treatment with two AT1 receptor blockers on diameter of pial arterioles in SHR.Electroacupuncture improves cerebral blood flow and attenuates moderate ischemic injury via Angiotensin II its receptors-mediated mechanism in rats.Blockade of Central Angiotensin II AT1 Receptor Protects the Brain from Ischemia/Reperfusion Injury in Normotensive Rats.Elevated blood pressure in the acute phase of stroke and the role of Angiotensin receptor blockers.Mechanisms underlying the cerebral microvascular responses to angiotensin II-induced hypertension.The renin-angiotensin system in the brain: possible therapeutic implications for AT(1)-receptor blockers.Protecting against vascular disease in brainElevated vertebrobasilar artery resistance in neonatal spontaneously hypertensive ratsImpact of short-term treatment with telmisartan on cerebral arterial remodeling in SHRCerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke.Electroacupuncture increased cerebral blood flow and reduced ischemic brain injury: dependence on stimulation intensity and frequency.LIFE and SCOPE: what guidance do they offer alongside ALLHAT and ANBP2?The renin-angiotensin-aldosterone system in atrial fibrillation: a new therapeutic target?Gene expression suggests spontaneously hypertensive rats may have altered metabolism and reduced hypoxic toleranceAngiotensin II AT(1) receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disorders.Are angiotensin receptor blockers neuroprotective?Renin angiotensin system: A novel target for migraine prophylaxis.An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's diseaseTransgenic Mice Overexpressing Human Angiotensin I Receptor Gene Are Susceptible to Stroke Injury.Effect of Long-Term Treatment with Fimasartan on Transient Focal Ischemia in Rat Brain.Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.Candesartan ameliorates impaired fear extinction induced by innate immune activation.Renin angiotensin system gene polymorphisms and cerebral blood flow regulation: the MOBILIZE Boston study.Hypertension and cerebrovascular dysfunction
P2860
Q28077553-97D292B5-6D27-4893-8793-8A7BF4E82ED7Q28236507-72380D9E-9AA6-4295-B56C-61B1B5FE1AF6Q30407495-5929C676-20F1-4CD0-87D2-62E9AD291057Q30891538-AE25E2B1-F626-4DFC-AA79-3013959AF698Q33201684-6D1BC1BF-2639-4FF2-AE18-E266F0CD705AQ33369567-665D6E94-54FC-4A11-9C0F-65ED905252B6Q33441240-74C286F4-58D0-4520-A39C-0F3A2201324CQ33603185-A7ABB0B6-9290-41E5-AE0B-700AB09A5AA0Q34003492-FB3073F2-B682-4059-8B91-C7411BBE4A0FQ34018990-04AA0AE2-E98C-4403-B42F-7783F813F10FQ34088803-FFEA1D5C-2BE0-4D96-85F8-34058FA4989CQ34169364-25E2977A-808A-4C23-889E-A36DCA91E591Q34375649-EA7D4571-A009-4DA8-8392-2B7EE8E89C9EQ34390088-37707C65-812A-4651-BA11-A351D60F6BD7Q34407931-C99B861A-9856-454C-9C21-2AC4664B8E7FQ34544159-D4D54F3A-7FD9-4E8F-9094-69A4435CB222Q34567399-4748B55A-DF28-4A5D-B2BC-B0FABF7A07B2Q34595301-BF5129C7-186C-414E-A4F8-3DCAA02CC6EFQ34683895-7F99CD1A-B2EE-47C6-A544-C24B9E8A7690Q34761214-D29FBEAC-3168-497D-84E7-9C72BA196BE0Q34979773-CCC5B720-609E-40D3-9044-98E92212F5E5Q35108765-85685EC3-3D3C-49EE-85EE-47B6950E9BEEQ35355161-E4F8C5FE-07DA-4943-B53B-6E53AB12253DQ35534662-319821BA-8448-428F-BEC3-BE491A729AB3Q35601726-7373EE55-959A-4A96-AC13-59CEE8318C51Q35636620-94710AF8-83AA-4C1E-AF85-34949EDD07F3Q35671248-72C59D21-21B0-4927-9467-063686281D71Q35810317-8F2FC1B0-FAAA-4561-B5DB-74FFBD734B49Q35827935-AF1F4CDD-8352-4E31-8134-AEAAA58C8B88Q35838481-64D7E6B9-2C3A-4870-BF2E-813DC49DD384Q35890377-9407A00A-673E-49E8-A73E-B99B7345C755Q35907609-637D7453-4B57-4A17-85EE-783282E5E018Q35921102-1B305D6B-8552-45E4-8A1F-BE65E7F05498Q36095573-58053442-32CE-455B-8D10-B92421EE619DQ36216393-F2284028-D4A2-4D40-88DE-80A3E45C7D17Q36283707-29E9A670-39ED-46C6-9899-FD7D37D3C1AAQ36410269-AC2D0FC9-D1E2-4223-B41B-5B40314C3D36Q36471452-33A78226-F4D0-4627-9B2A-F2089CE2B2F5Q36584563-C0B6B0CD-D644-4FA5-8ECF-EBE189C83DC7Q36777769-C67E7913-5DEC-4C13-983A-1637DD8E99BF
P2860
Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Angiotensin II AT(1) blockade ...... ontaneously hypertensive rats.
@ast
Angiotensin II AT(1) blockade ...... ontaneously hypertensive rats.
@en
type
label
Angiotensin II AT(1) blockade ...... ontaneously hypertensive rats.
@ast
Angiotensin II AT(1) blockade ...... ontaneously hypertensive rats.
@en
prefLabel
Angiotensin II AT(1) blockade ...... ontaneously hypertensive rats.
@ast
Angiotensin II AT(1) blockade ...... ontaneously hypertensive rats.
@en
P2093
P1433
P1476
Angiotensin II AT(1) blockade ...... ontaneously hypertensive rats.
@en
P2093
P304
P356
10.1161/01.STR.31.10.2478
P407
P577
2000-10-01T00:00:00Z